Rhinase D Gel Moisturizing Nasal Decongestant
- Manufacturer
- Profounda Inc
- Effective date
- 2025-12-18
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-06-01 01:26:34
Label at a glance#
ProductRhinase D Gel Moisturizing Nasal Decongestant
Active ingredientOXYMETAZOLINE HYDROCHLORIDE
Label structure13 sections
Contacts and useful links#
Label contents#
Full prescribing information#
Active Ingredient........Purpose
Oxymetalozine 0.05%.....Nasal Decongestant
OTC - ASK DOCTOR SECTION
Stop use and ask a doctor if symptoms persist
OTC - PURPOSE SECTION
USES
- temporarily relieves nasal congestion due to:
- common cold - Hay fever - upper respiratory allergies
- temporarily relieves sinus congestion and pressure
-shrinks swollen nasal membranes so you can breathe more freely
OTC - WHEN USING SECTION
- do not use more than directed
- do not use for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen.
- temporary discomfort such as burning, stinging, sneezing or an increase in nasal discharge may occur
- use of this container by more than one person may spread infection.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or brreast feeding ask a health professional before use
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed get medical help or contact a poisen control center right away
OTC - QUESTIONS SECTION
Please call 407-270-7790
DOSAGE & ADMINISTRATION SECTION
Adults and Children 6 to under 12 years of age (with adult supervision) Place a small amount in each nostril and inhale well back into the nasal passages, not more often than every 10-12 hours. Do not exceed 2 doses in any 24 hour period.
children under 6 years of age ask a doctor.
To Use: press down grooved white cap firmly and turn counter clockwise . Secure cap after use.
WARNINGS SECTION
Ask a doctor if you have - heart disease - high blood pressure - trouble urinating due to a thyroid disease - diabetes - enlarged prostrate gland
INACTIVE INGREDIENT SECTION
Inactive ingredients: Purified Water, Carbopol, Sodium Carboxymethylcellulose,
Sodium
INDICATIONS & USAGE SECTION
USES
- temporarily relieves nasal congestion due to:
- common cold - Hay fever - upper respiratory allergies
- temporarily relieves sinus congestion and pressure
-shrinks swollen nasal membranes so you can breathe more freely
INDICATIONS & USAGE SECTION
USES
- temporarily relieves nasal congestion due to:
- common cold - Hay fever - upper respiratory allergies
- temporarily relieves sinus congestion and pressure
-shrinks swollen nasal membranes so you can breathe more freely
RhinaseD_Sachet_3g_200422_052920-FIN.jpg
Rhinase D Gel
Oxymetazoline HCL 0.05%
Moisturing Nasal Decongestant
12 hour nasal relief for congestion caused by colds and allergies
Profounda logo
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69051-202-01 | 2023-10-05 | C162847 | 48780-1 | f386c649-f1fd-0266-e053-dadaa90a7c1a | Rhinase D (Oxymetazoline HCL) Moisturizing Nasal Decongestant 3 g |
| 69051-202-01 | 2023-01-30 | C162847 | 48780-1 | f386c649-f1fd-0266-e053-dadaa90a7c1a | Rhinase D (Oxymetazoline HCL) Moisturizing Nasal Decongestant 3 g |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69051-202-01 | Rhinase D Gel Moisturizing Nasal Decongestant | 3 {VP} in 1 TUBE | JELLY | 3 | 4 | |
| 69051-202-01 | Rhinase D Gel Moisturizing Nasal Decongestant | 3 in 1 TUBE | JELLY | 3 | 4 |
Products#
Every source-derived product name is available through these pages.
- Rhinase D Gel Moisturizing Nasal Decongestant
- Oxymetazoline HCL 0.5%
- CARBOXYMETHYLCELLULOSE
- WATER
- OXYMETAZOLINE HYDROCHLORIDE
- OXYMETAZOLINE
- BENZALKONIUM CHLORIDE
- POTASSIUM CHLORIDE
- SODIUM CHLORIDE
- POLYETHYLENE GLYCOL 10000
- DIPROPYLENE GLYCOL
- CARBOMER 934
- SODIUM HYDROXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 69051-202 | 69051-202-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CARBOXYMETHYLCELLULOSE | 05JZI7B19X | IACT |
| WATER | 059QF0KO0R | IACT |
| OXYMETAZOLINE HYDROCHLORIDE | K89MJ0S5VY | ACTIB |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| POTASSIUM CHLORIDE | 660YQ98I10 | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| POLYETHYLENE GLYCOL 10000 | H57W405143 | IACT |
| DIPROPYLENE GLYCOL | E107L85C40 | IACT |
| CARBOMER 934 | Z135WT9208 | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 535af964-48ed-3d19-e063-6394a90a2b36 | b6fb78e0-2a28-ab01-e053-2a95a90a3c76 | 2026-06-03 | Warnings | b6fb78e0-2a28-ab01-e053-2a95a90a3c76 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.